Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Quality of life with malignant bowel obstruction: Provider assessed health state utilities
    Meeting Abstract

    Wong, S. L.; Wong, D.; Elkin, E. B.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Melanoma patients with positive sentinel nodes who do not undergo completion lymphadenectomy: A multi-institutional study
    Meeting Abstract

    Wong, S. L.; Thompson, J. F.; Gershenwald, J. E.; Leong, S. P.; Reintgen, D. S.; Sabel, M. S.; Gutman, H.; McMasters, K. M.; Tyler, D. S.; Coit, D. G.
    Annals of Surgical Oncology (2005)

    Fulltext@MSK | Save
  • Osteonecrosis of the jaw in patients with metastatic breast cancer
    Meeting Abstract

    Van Poznak, C. H.; Estilo, C. L.; Sauter, N. P.; Williams, T.; Tunick, S.; Halpern, J.; Hudis, C. A.; Huryn, J. M.
    Journal of Bone and Mineral Research (2005)

    Fulltext@MSK | Save
  • Life expectancy of patients with bone metastases from breast cancer: A retrospective, single institution review
    Meeting Abstract

    Van Poznak, C.; Martin, J.; Hudis, C.
    Cancer Treatment Reviews (2005)

    Fulltext@MSK | Save
  • A phase II trial of letrozole in combination with bevacizumab, an anti-VEGF antibody, in patients with hormone receptor-positive metastatic breast cancer
    Meeting Abstract

    Traina, T. A.; Dickler, M. N.; Caravelli, J. F.; Yeh, B. M.; Brogi, E.; Panageas, K.; Flores, S. A.; Norton, L.; Park, J.; Hudis, C.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • A feasibility study of an aromatase inhibitor (Al), letrozole (L) and the antibody to vascular endothelial growth factor (VEGF), bevacizurnab (B), in patients (pts) with hormone receptor-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Traina, T. A.; Dickler, M. N.; Caravelli, J. F.; Yeh, B. M.; Brogi, E.; Panageas, K.; Flores, S. A.; Norton, L.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Implications of ductal carcinoma in situ in predicting BRCA status in Ashkenazi Jewish women
    Meeting Abstract

    Sukumvanich, P.; Wadsworth, E.; Nafa, K.; Kolachana, P.; Borgen, P. I.; Robson, M. E.; Offit, K.
    Annals of Surgical Oncology (2005)

    Fulltext@MSK | Save
  • FLT PET as a non-invasive marker of response to MEK inhibition
    Meeting Abstract

    Solit, D. B.; Santos, E.; Pratilas, C.; Moroz, M.; Blasberg, R.; Sebolt-Leopold, J.; Larson, S. M.; Rosen, N.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Phase 1 pharmacokinetic and pharmacodynamic trial of docetaxel and 17AAG (17-allylamino-17-demethoxygeldanamycin)
    Meeting Abstract

    Solit, D. B.; Egorin, M.; Kopil, C.; Delacruz, A.; Shaffer, D.; Slovin, S.; Morris, M.; Kelly, W. K.; Rosen, N.; Scher, H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Inhibitors of Hsp90 induce the degradation of HER2 and inhibit the growth of HER2-dependent breast tumors
    Meeting Abstract

    Solit, D. B.; Basso, A.; Smith-Jones, P.; Modi, S.; Norton, L.; Larson, S.; Neckers, L.; Scher, H.; Hudis, C.; Rosen, N.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save